Mwanzo069620 • KRX
add
Daewoong Pharma
Bei iliyotangulia
₩ 126,100.00
Bei za siku
₩ 126,500.00 - ₩ 129,600.00
Bei za mwaka
₩ 100,100.00 - ₩ 164,400.00
Thamani ya kampuni katika soko
1.49T KRW
Wastani wa hisa zilizouzwa
elfu 33.52
Uwiano wa bei na mapato
14.35
Mgao wa faida
0.46%
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (KRW) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 358.47B | 5.16% |
Matumizi ya uendeshaji wa biashara | 144.74B | 7.00% |
Mapato halisi | 28.28B | 81.53% |
Kiwango cha faida halisi | 7.89 | 72.65% |
Mapato kwa kila hisa | — | — |
EBITDA | 49.20B | 21.91% |
Asilimia ya kodi ya mapato | -3.14% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (KRW) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 107.51B | -37.49% |
Jumla ya mali | 1.92T | 12.48% |
Jumla ya dhima | 971.10B | 13.73% |
Jumla ya hisa | 951.35B | — |
hisa zilizosalia | 11.51M | — |
Uwiano wa bei na thamani | 1.78 | — |
Faida inayotokana na mali | 4.90% | — |
Faida inayotokana mtaji | 6.10% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (KRW) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 28.28B | 81.53% |
Pesa kutokana na shughuli | 22.21B | -65.56% |
Pesa kutokana na uwekezaji | -51.68B | -61.59% |
Pesa kutokana na ufadhili | 36.58B | 3,410.29% |
Mabadiliko halisi ya pesa taslimu | 6.89B | -77.97% |
Mtiririko huru wa pesa | -35.44B | -283.86% |
Kuhusu
Daewoong Pharmaceutical Co., Ltd. is a pharmaceutical company headquartered in Seoul, South Korea. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products, including prescription and over-the-counter healthcare products. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1945
Tovuti
Wafanyakazi
1,715
